Acyclovir

Acyclovir

SCHEMBL8052815

CC1(C)OCC(CO)O1.Nc1nc2c(ncn2COCCO)c(=O)[nH]1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PNP P00491 8/20 0.68
▸ HBB P68871 2/20 0.68
▸ BLM P54132 2/20 0.68
▸ USP2 O75604 1/20 0.68
▸ TSHR P16473 1/20 0.68
▸ EDNRA P25101 1/20 0.68
▸ HTR2A P28223 1/20 0.68
▸ RECQL P46063 1/20 0.68
▸ HSD17B10 Q99714 1/20 0.68
▸ HPRT1 P00492 3/20 0.55
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ MAPK1 P28482 1/20 0.51
▸ POLG P54098 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ VCP P55072 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acyclovir SCHEMBL5930213 0.89 PNP (0.60) PNPHBBBLMUSP2TSHR
Acyclovir SCHEMBL5930416 0.86 PNP (0.65) PNPHBBBLMUSP2TSHR
Acyclovir SCHEMBL16061503 0.82 PNP (0.95) PNPHBBBLMUSP2TSHR
Acyclovir SCHEMBL3664893 0.82 PNP (1.00) PNPHBBBLMUSP2TSHR
Acyclovir SCHEMBL3175 0.82 PNP (1.00) PNPHBBBLMUSP2TSHR
Acyclovir SCHEMBL2269160 0.82 PNP (1.00) PNPHBBBLMUSP2TSHR
Acyclovir SCHEMBL8651162 0.81 PNP (0.88) PNPHBBBLMUSP2TSHR
Acyclovir SCHEMBL9479083 0.81 PNP (0.93) PNPHBBBLMUSP2TSHR
Acyclovir SCHEMBL19031784 0.81 PNP (0.97) PNPHBBBLMUSP2TSHR
Acyclovir SCHEMBL6239258 0.81 PNP (0.97) PNPHBBBLMUSP2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6015573-A TREATMENT OF RESISTANT HERPES VIRUS WITH NUCLEOSIDE PHOSPHATE ESTERS RESOLUTION PERFORMANCE PRODUCTS LLC 2000-01-18 — — US disclosed
US-5879700-A TREATING HERPES VIRUS INFECTIONS HOSTETLER KARL Y (US) 1999-03-09 — — US disclosed
EP-0831794-A4 ACYCLOVIR DERIVATIVES FOR TOPICAL USE HOSTETLER KARL Y (US) 1998-11-04 — — EP disclosed
US-5756116-A VIRICIDES USING ACYCLOVIR RESISTANT STRAIN OF HERPES VIRUS HOSTETLER KARL Y (US) 1998-05-26 — — US disclosed
EP-0831794-A1 ACYCLOVIR DERIVATIVES FOR TOPICAL USE HOSTETLER, Karl Y. (US) 1998-04-01 — — EP disclosed
EP-0746319-A4 ACYCLOVIR DERIVATIVES FOR TOPICAL USE HOSTETLER KARL Y (US) 1997-11-05 — — EP disclosed
WO-1996040088-A1 ACYCLOVIR DERIVATIVES FOR TOPICAL USE HOSTETLER KARL Y (US) 1996-12-19 — — WO disclosed
EP-0746319-A1 ACYCLOVIR DERIVATIVES FOR TOPICAL USE HOSTETLER, Karl Y. (US) 1996-12-11 — — EP disclosed
US-5580571-A ACYCLOIR MONO OR DIPHOSPHATE; TOPICAL USE IN HERPES VIRUSINFECTIONS HOSTETLER KARL Y (US) 1996-12-03 — — US disclosed
WO-1994026273-A1 ACYCLOVIR DERIVATIVES FOR TOPICAL USE HOSTETLER KARL Y (US) 1994-11-24 — — WO disclosed
Send feedback